logo

For the Inventor, By the Inventor

Hyderabad Telangana, India

Venkata Sunil Kumar Indukuri

This inventor holds 26 USPTO granted patents and 1 published patent application and 13 EPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Laurus Labs Private Limited. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venkata Sunil Kumar Indukuri. Retrieved from https://idiyas.com/inventor/venkata-sunil-kumar-indukuri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 61.5

 

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Kukatpally, IN (2012)
  • Hyderabad, IN (2013 - 2022)

Company Filing History:

goldMedal26 out of 66 
 
Laurus Labs Private Limited
 patents

Years Active: 2012-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Pazopanib
SGLT2 Inhibitors
Enzalutamide
Carfilzomib
Pirfenidone
Dolutegravir
Ivacaftor
Atazanavir
Sunitinib
Montelukast
Tenofovir
Polymorphs
26 patents (USPTO):Explore Patents
1. 11427570 - Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof (2022-08-30),
2. 11299477 - Process for the preparation of Pazopanib or a pharmaceutically acceptable salt thereof (2022-04-12),
3. 11066368 - Process for the preparation and particle size reduction of pirfenidone (2021-07-20),
4. 11040961 - Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof (2021-06-22),
5. 10836753 - Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof (2020-11-17),
6. 10800809 - Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof (2020-10-13),
7. 10738038 - Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof (2020-08-11),
8. 10730859 - Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof (2020-08-04),
9. 10669264 - Process for the preparation of macitentan (2020-06-02),
10. 10654872 - Polymorphs of dolutegravir and salts thereof (2020-05-19),
11. 10647729 - Polymorphs of dolutegravir and salts thereof (2020-05-12),
12. 10626091 - Process for the preparation of enzalutamide (2020-04-21),
13. 10597404 - Polymorphs of dolutegravir and salts thereof (2020-03-24),
14. 10428053 - Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof (2019-10-01),
15. 10364269 - Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof (2019-07-30),

Title: Venkata Sunil Kumar Indukuri: Innovator in Pharmaceutical Processes

Introduction

Venkata Sunil Kumar Indukuri is an accomplished inventor based in Hyderabad, Telangana, India. With a remarkable record of 26 patents to his name, he has made significant contributions to the field of pharmaceuticals, particularly in the development and preparation of complex compounds.

Latest Patents

One of his most recent innovations is the "Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof." This invention pertains to an improved method for synthesizing pazopanib, as well as novel polymorphic forms of pazopanib hydrochloride and its intermediates. This advancement is noteworthy as pazopanib is a key therapeutic agent in the treatment of various cancers.

Career Highlights

Venkata currently works at Laurus Labs Private Limited, a leading pharmaceutical company known for its commitment to quality and innovation. His work at Laurus Labs has allowed him to leverage his expertise in creating processes that improve the yield and efficiency of drug production, enhancing the potential for making life-saving medications more accessible.

Collaborations

Throughout his career, Venkata has collaborated with notable coworkers such as Satyanarayana Chava and Ram Thaimattam. These partnerships have fostered a creative environment that encourages the sharing of ideas and innovative solutions, further driving advancements in pharmaceutical sciences.

Conclusion

Venkata Sunil Kumar Indukuri exemplifies the spirit of innovation within the pharmaceutical industry. With his extensive portfolio of patents and ongoing contributions at Laurus Labs Private Limited, he continues to pave the way for new developments that could significantly impact patient care and treatment options in the future. His work not only demonstrates his commitment to science but also underscores the vital role of inventors in shaping the landscape of modern healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…